Article
Gene Therapy in Hemophilia: Recent Advances
17 Jul 2021
Abstract excerpt
Hemophilia is a monogenic mutational disease affecting coagulation factor VIII or factor IX genes. The palliative treatment of choice is based on the use of safe and effective recombinant clotting factors. Advanced therapies will be curative, ensuring stable and durable concentrations of the defective circulating factor. Results have so far been encouraging in terms of levels and times of expression using mainly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
